We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$14.5B
AUM Growth
+$59.6M
Cap. Flow
-$238M
Cap. Flow %
-1.65%
Top 10 Hldgs %
15.54%
Holding
2,654
New
131
Increased
878
Reduced
781
Closed
88

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$64.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.3M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$13M
4
DXC icon
DXC Technology
DXC
+$11.4M
5
ETP
Energy Transfer Partners, L.P.
ETP
+$9.97M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$20.3M
2
ETP
Energy Transfer Partners L.p.
ETP
+$10.9M
3
WWAV
The WhiteWave Foods Company
WWAV
+$9.66M
4
CSC
Computer Sciences
CSC
+$9.08M
5
AAPL icon
Apple
AAPL
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 14.52%
2 Technology 14.04%
3 Healthcare 11.73%
4 Industrials 10.12%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DPLO
1726
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$474K ﹤0.01%
32,010
– –
IMGN
1727
DELISTED
Immunogen Inc
IMGN
$473K ﹤0.01%
66,517
– –
CWST icon
1728
Casella Waste Systems
CWST
$5.79B
$472K ﹤0.01%
28,771
– –
XENT
1729
DELISTED
Intersect ENT, Inc
XENT
$472K ﹤0.01%
16,873
-1,074
-6% -$24.3K
AMPH icon
1730
Amphastar Pharmaceuticals
AMPH
$858M
$470K ﹤0.01%
26,305
– –
VEEV icon
1731
Veeva Systems
VEEV
$41B
$470K ﹤0.01%
7,670
+1,076
+16% +$62.1K
SNCR
1732
DELISTED
Synchronoss Technologies
SNCR
$469K ﹤0.01%
3,170
– –
GMS
1733
DELISTED
GMS Inc
GMS
$468K ﹤0.01%
16,642
+11,452
+221% +$384K
ADAM
1734
Adamas Trust
ADAM
$913M
$468K ﹤0.01%
18,812
– –
HSKA
1735
DELISTED
Heska Corp
HSKA
$467K ﹤0.01%
4,574
-279
-6% -$27.5K
MRTN icon
1736
Marten Transport
MRTN
$1.22B
$466K ﹤0.01%
42,530
– –
PJT icon
1737
PJT Partners
PJT
$4.36B
$465K ﹤0.01%
11,558
– –
CAC icon
1738
Camden National
CAC
$990M
$464K ﹤0.01%
10,810
– –
PFBC icon
1739
Preferred Bank
PFBC
$1.26B
$464K ﹤0.01%
8,676
+299
+4% +$15.4K
EGRX
1740
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$464K ﹤0.01%
5,882
-354
-6% -$28.9K
EPZM
1741
DELISTED
Epizyme, Inc
EPZM
$463K ﹤0.01%
30,680
– –
COBZ
1742
DELISTED
CoBiz Financial,Inc
COBZ
$463K ﹤0.01%
26,608
– –
PRO
1743
DELISTED
PROS Holdings
PRO
$462K ﹤0.01%
16,872
+263
+2% +$6.87K
WBC
1744
DELISTED
WABCO HOLDINGS INC.
WBC
$462K ﹤0.01%
3,623
-6
-0.2% -$718
CZR
1745
DELISTED
Caesars Entertainment Corporation
CZR
$462K ﹤0.01%
38,533
– –
ARMK icon
1746
Aramark
ARMK
$16.1B
$459K ﹤0.01%
15,498
+98
+0.6% +$2.69K
ATRO icon
1747
Astronics
ATRO
$4.34B
$459K ﹤0.01%
20,775
+3,869
+23% +$86.6K
AXDX
1748
DELISTED
Accelerate Diagnostics
AXDX
$459K ﹤0.01%
1,679
+61
+4% +$16.5K
TELL
1749
DELISTED
Tellurian Inc.
TELL
$459K ﹤0.01%
+45,796
New +$484K
HEES
1750
DELISTED
H&E Equipment Services
HEES
$458K ﹤0.01%
22,455
– –
68 69
70
71 72

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2017 Portfolio in Review

As of Q2 2017, Metropolitan Life Insurance Company (MetLife) held 2,654 positions worth $14.5B, up 0.41% from $14.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2017 filing shows 131 new, 878 increased, 781 reduced and 88 closed positions. Its largest new stake was DXC Technology: 172,294 shares worth $11.4M. The largest sale was Yahoo Inc, an estimated $20.3M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2017 buy was DXC Technology: 172,294 shares worth $11.4M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2017, an estimated $64.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2017 reduction was Apple, cutting an estimated $9.01M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Yahoo Inc in Q2 2017, selling an estimated $20.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 16% of its $14.5B portfolio in Q2 2017.
  • Metropolitan Life Insurance Company (MetLife) opened 131 new positions and closed 88 in Q2 2017.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 0.41% quarter-over-quarter to $14.5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2017, filed 14 Aug 2017.